Tempest Therapeutics (TPST) Earnings Analysis
Tempest Therapeutics (TPST) next reports earnings on 2026-08-10, consensus EPS -0.3 USD. Last quarter (2026-05-14) it missed with EPS -2.53 USD vs -0.28 USD est (-803.6%). It has beaten estimates in 3/4 recent quarters (75%). Trailing P/E -0.15.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does TPST next report earnings?
| Next earnings date | 2026-08-10 |
|---|---|
| Consensus EPS estimate | -0.3 USD |
| Revenue estimate | n/a |
TPST earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-14 | -2.53 USD | -0.28 USD | -803.6% | Miss |
| 2026-03-31 | -0.62 USD | -0.62 USD | 0% | Beat |
| 2025-08-11 | -2.07 USD | -3.23 USD | +35.9% | Beat |
| 2024-08-08 | -5.46 USD | -6.11 USD | +10.6% | Beat |
Beat rate: 3/4 (75%) over reported quarters with consensus data.
TPST valuation and analyst view
| Trailing P/E | -0.15 |
|---|---|
| Trailing EPS | -3.94252 USD |
| Price / book | 12.65 |
| Dividend yield | 0.00% |
| Market cap | 0.00B |
| Analyst consensus | Buy (4 buy / 1 hold / 0 sell) |
Related research pages
Frequently asked questions
When is Tempest Therapeutics (TPST)'s next earnings date?
Tempest Therapeutics is next scheduled to report on 2026-08-10, with a consensus EPS estimate of -0.3 USD.
Did TPST beat earnings last quarter?
In its 2026-05-14 report, TPST posted EPS of -2.53 USD versus a -0.28 USD estimate — a miss of 803.6%.
What is TPST's earnings track record?
Over the last 4 reported quarters with consensus data, TPST beat estimates 3 times (75%).
What is TPST's current P/E ratio and EPS?
TPST trades at a trailing P/E of -0.15 on trailing EPS of -3.942517801385397 USD.
What do analysts rate TPST?
Analyst consensus is "Buy" across 5 ratings (0 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell).